Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis
about
Calcineurin plays key roles in the dimorphic transition and virulence of the human pathogenic zygomycete Mucor circinelloidesPosaconazole exhibits in vitro and in vivo synergistic antifungal activity with caspofungin or FK506 against Candida albicansAntifungal Therapy: New Advances in the Understanding and Treatment of MycosisHuman Fungal Pathogens of Mucorales and Entomophthorales.Antifungal pharmacokinetics and pharmacodynamicsThe calcineurin pathway inhibitor tacrolimus enhances the in vitro activity of azoles against Mucorales via apoptosisHuman pathogenic bacteria, fungi, and viruses in Drosophila: disease modeling, lessons, and shortcomings.Pathogenesis and host defence against Mucorales: the role of cytokines and interaction with antifungal drugs.Calcineurin orchestrates dimorphic transitions, antifungal drug responses and host-pathogen interactions of the pathogenic mucoralean fungus Mucor circinelloides.Calcineurin in fungal virulence and drug resistance: Prospects for harnessing targeted inhibition of calcineurin for an antifungal therapeutic approach.The anti-Aspergillus drug pipeline: Is the glass half full or empty?Efficacy of Posaconazole in a Murine Model of Systemic Infection by Saprochaete capitata.Heat shock protein 90 and calcineurin pathway inhibitors enhance the efficacy of triazoles against Scedosporium prolificans via induction of apoptosis.FKBP12-Dependent Inhibition of Calcineurin Mediates Immunosuppressive Antifungal Drug Action in MalasseziaMethodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.An insight into new strategies to combat antifungal drug resistance
P2860
Q27333075-CC191664-1B76-47AD-BE4D-6F8D522DDF0AQ28487653-DF058F09-D8DB-4590-8F55-90A58628A387Q28818603-C290681A-EFA2-4CC0-A022-37E0E9B811F5Q35245238-791430E4-29EF-4EDA-9603-9099720FB157Q35663841-4987CF8E-1CA8-4D8D-8BB1-F26CFD212A2AQ37264097-385E2D22-526D-44B9-8D16-C66ABB54AEEAQ37641493-7EAD1C3A-A82D-4EAC-A4D5-C67A8E6F2541Q38245046-A7F0DEFD-73E2-4B7A-8298-C2C9CABC33C5Q38871002-356BE3F9-FDB3-4182-AA6D-85BF52C8B7B4Q38871364-0FBAC325-0DB8-4D19-A60D-0D9D2ECA37D5Q38937577-9C956D0B-96A9-4C74-B25F-787104FFB324Q40988680-40DB0175-C9BF-4C6B-8B0B-3140819D7AE6Q42212950-FD46C3AB-F26A-4154-BB5A-64020D3D673AQ42638827-2DD6A9BB-1996-4491-9152-4B80A48C67F3Q55511181-72E8FBAC-8B93-4A0B-8F7E-7BCA5F69422AQ59135042-0C58DC85-BED4-410D-88B4-4353EB1B14F2
P2860
Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Tacrolimus enhances the potenc ...... rimental model of mucormycosis
@ast
Tacrolimus enhances the potenc ...... rimental model of mucormycosis
@en
type
label
Tacrolimus enhances the potenc ...... rimental model of mucormycosis
@ast
Tacrolimus enhances the potenc ...... rimental model of mucormycosis
@en
prefLabel
Tacrolimus enhances the potenc ...... rimental model of mucormycosis
@ast
Tacrolimus enhances the potenc ...... rimental model of mucormycosis
@en
P2093
P2860
P356
P1476
Tacrolimus enhances the potenc ...... rimental model of mucormycosis
@en
P2093
Dimitrios P Kontoyiannis
Leyla Best
Nathaniel Albert
Ronen Ben-Ami
Russell E Lewis
Thomas J Walsh
P2860
P304
P356
10.1093/INFDIS/JIS767
P407
P577
2012-12-13T00:00:00Z